Nuvation Bio Inc. Class A Common Stock (NY:NUVB)

4.795 -0.155 (-3.13%)

Delayed Quote Updated: 2:21 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nuvation Bio Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 Next >

NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024 ↗

May 14, 2024

NUVB stock results show that Nuvation Bio beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update

May 14, 2024

From Nuvation Bio Inc.

Via Business Wire

Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

April 24, 2024

From Nuvation Bio Inc.

Via Business Wire

Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday ↗

April 19, 2024

Via Benzinga

Nuvation Bio Completes Acquisition of AnHeart Therapeutics

April 10, 2024

From Nuvation Bio Inc.

Via Business Wire

ProfoundBio Discovers The Joys Of Having A Wealthy Owner ↗

April 08, 2024

Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a...

Via Benzinga

Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

April 03, 2024

U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday.

Via Benzinga

Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal ↗

March 30, 2024

South Korea’s AriBio out-licensed China rights for AR1001, an Alzheimer’s disease candidate, in an agreement worth up to $770 million. The company acquiring the asset asked to remain anonymous because...

Via Talk Markets

Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer

March 28, 2024

From Nuvation Bio Inc.

Via Business Wire

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 27, 2024

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 27, 2024

Via Benzinga

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday ↗

March 27, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 27, 2024

Via Benzinga

Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

March 27, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket ↗

March 27, 2024

Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 27, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news!

Via InvestorPlace

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 26, 2024

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 26, 2024

Via Benzinga

Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday ↗

March 26, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 25, 2024

Via Benzinga

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

March 25, 2024

From Nuvation Bio Inc.

Via Business Wire

Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 25, 2024

U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.

Via Benzinga

Topics Stocks

Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors

March 14, 2024

From Nuvation Bio Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 14, 2024

Via Benzinga

Biotech’s Role in Addressing the Pancreatic Cancer Emergency

March 14, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

Via FinancialNewsMedia

Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

February 29, 2024

From Nuvation Bio Inc.

Via Business Wire

Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors

January 08, 2024

From Nuvation Bio Inc.

Via Business Wire

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

January 08, 2024

From Nuvation Bio Inc.

Via Business Wire

Nuvation Bio Announces Departure of Chief Financial Officer

November 13, 2023

From Nuvation Bio Inc.

Via Business Wire

Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

November 02, 2023

From Nuvation Bio Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.